Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-12-002718
Filing Date
2012-03-23
Accepted
2012-03-23 16:53:23
Documents
13
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT gfr_10k-123111.htm 10-K 1139871
2 SUBSIDIARIES ex21-1.htm EX-21.1 7465
3 CERTIFICATION CEO ex31-1.htm EX-31.1 10949
4 CERTIFICATION CFO ex31-2.htm EX-31.2 10842
5 CERTIFICATION CEO ex32-1.htm EX-32.1 6234
6 CERTIFICATION CFO ex32-2.htm EX-32.2 6307
13 IMAGE gfr_10k-1231110.jpg GRAPHIC 8914
  Complete submission text file 0001437749-12-002718.txt   4055642

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE gfrpob-20111231.xml EX-101.INS 665493
8 XBRL TAXONOMY EXTENSION SCHEMA gfrpob-20111231.xsd EX-101.SCH 20937
9 XBRL TAXONOMY EXTENSION CALCULATION gfrpob-20111231_cal.xml EX-101.CAL 27542
10 XBRL TAXONOMY EXTENSION DEFINITION gfrpob-20111231_def.xml EX-101.DEF 94461
11 XBRL TAXONOMY EXTENSION LABELS gfrpob-20111231_lab.xml EX-101.LAB 124310
12 XBRL TAXONOMY EXTENSION PRESENTATION gfrpob-20111231_pre.xml EX-101.PRE 109678
Mailing Address 9160 E. DEER TRAIL 9160 E. DEER TRAIL TUCSAN AZ 85710
Business Address SUITE 11405 - 201A STREET MAPLE RIDGE A1 V2X 0Y3 5205771516
GFR PHARMACEUTICALS INC (Filer) CIK: 0001096294 (see all company filings)

EIN.: 770517964 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27959 | Film No.: 12712467
SIC: 2834 Pharmaceutical Preparations